|
Video: What is a Stock Split?
|
|
Nexalin Technology is a medical device company that designs and develops neurostimulation products to help combat the ongoing global mental health epidemic. Co. has developed a medical device, referred to as Generation 1, that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Co. has designed and developed new waveform technology to be emitted at 15 milliamps - referred to as Generation 2 which can penetrate deeper into the brain and stimulate associated structures of mental illness. Generation 2 is being tested in pilot trials, for anxiety, insomnia, and depression in the United States. According to our Nexalin Technology stock split history records, Nexalin Technology has had 0 splits. | |
|
Nexalin Technology (NXL) has 0 splits in our Nexalin Technology stock split history database.
Looking at the Nexalin Technology stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Nexalin Technology shares, starting with a $10,000 purchase of NXL, presented on a split-history-adjusted basis factoring in the complete Nexalin Technology stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/19/2022 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$1.69 |
|
End price/share: |
$1.69 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
0.00% |
|
Average Annual Total Return: |
0.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,000.00 |
|
Years: |
1.62 |
|
|
|
|
|